Latest News

June 5, 2010

Merge, LLC launches the Platinum Study Program for treatment of Alzheimer’s disease.

Merge, LLC announced today that is had launched the Platinum program, a series of global studies designed to evaluate Trial Medication in the Alzheimer’s Disease patient population.

Full information: www.mergellc.com/news

June 5, 2010

Merge, LLC launches the Platinum Study Program for treatment of Alzheimer’s disease.

Merge, LLC announced today that is had launched the Platinum program, a series of global studies designed to evaluate Trial Medication in the Alzheimer’s Disease patient population.

Full information: www.mergellc.com/news

June 5, 2010

Merge, LLC launches the Platinum Study Program for treatment of Alzheimer’s disease.

Merge, LLC announced today that is had launched the Platinum program, a series of global studies designed to evaluate Trial Medication in the Alzheimer’s Disease patient population.

Full information: www.mergellc.com/news